Admission Date:  [**2104-8-15**]              Discharge Date:   [**2104-9-9**]


Service: VSURG

Allergies:
Penicillins / Cephalosporins / Carbapenem / Aztreonam

Attending:[**First Name3 (LF) 1781**]
Chief Complaint:
Fevers and confusion, new

Major Surgical or Invasive Procedure:
Right foot debridment [**2104-8-27**]

History of Present Illness:
Patient recently discharged form our hospital areturn to ER with
fever,chill and confusion. Vascular consulted during ER
evaluation. Patient now admitted to vascular service for
continued care(.Note on physical exam in ER. rt. leg cellulitis
and foot color changes.Patient's PCP and vascular [**Name9 (PRE) 19670**] opted
for conserative treatment. He was started on Ceftriaxone and
flagyl )

Past Medical History:
Diabetes type one, insulin dependant
COPD
CAD, s/p MI [**2094**]
pneumonia, recent treated
PVD
esophgitis
hypercholestremia
history of CVA right sided
s/p CABGsx4
s/p rt. toe amputations #3&4


Social History:
not avaible

Family History:
unknown

Physical Exam:
Vital signs: 100.7-89-16 92/52 oxygen saturation on 6liter/nasal
cannula 98%
General: oriented x2. No acute distress
Heart: irregular irregular rythmn
Lungs: corase crackles LLL
ABD: bengin
EXT: right foot: large dorsal foot  ersovie ulcer, not
gangrenous with erthyema, warm to palpation and toe blanching
Pulses: radial and femoral pulses palpable bilaterally,
popliteal biphasic
signal bilaterally. right pedal pulses moophasic signal. Left
pedal pulses biphasic signal.
Neuro Ox2, grossly intact

Pertinent Results:
[**2104-8-14**] 10:21PM   LACTATE-2.0
[**2104-8-14**] 10:10PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.017
[**2104-8-14**] 10:10PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-NEG
GLUCOSE-1000 KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0
LEUK-NEG
[**2104-8-14**] 10:10PM URINE  RBC-0-2 WBC-0 BACTERIA-NONE YEAST-NONE
EPI-<1
[**2104-8-14**] 10:00PM   GLUCOSE-65* UREA N-19 CREAT-0.7 SODIUM-137
POTASSIUM-4.1 CHLORIDE-97 TOTAL CO2-32* ANION GAP-12
[**2104-8-14**] 10:00PM   CK(CPK)-26*
[**2104-8-14**] 10:00PM   CK-MB-2 cTropnT-<0.01
[**2104-8-14**] 10:00PM   WBC-20.0* RBC-4.19* HGB-13.1* HCT-38.4*#
MCV-92 MCH-31.2 MCHC-34.0 RDW-13.8
[**2104-8-14**] 10:00PM   NEUTS-83.3* LYMPHS-10.9* MONOS-5.4 EOS-0.3
BASOS-0.2
[**2104-8-14**] 10:00PM   PLT COUNT-228
[**2104-8-14**] 10:00PM   PT-12.5 PTT-30.1 INR(PT)-1.0

Brief Hospital Course:
[**2104-8-15**] admitted vascular surgical service.right foot infection
continued on Cefriaxone and flagyl.Now with fever of 102.5 and
mental status changes in last twentfour hours. admitting chest
xray left lower pneumonia  antibiotics were changed to
vancomycin,levofloxcin and flagyl IV. The night of admission
patient became more confused, hypoglycemic with ? seizures  VS.
rigors and hypotension. He was transfered to ICU for hemodynamic
monitering. right internal jugular line was placed withut pneumo
thorax.Patient blood pressure responded to 2 liters of fluid
bolus.
Patient remained with low grade fever 100.5 but was
hemodynamically stable. Total WBC 21.A D10 IV drip was instuted
for his hypoglycemia.
[**2104-8-16**] [**Last Name (un) **] service was consulted for glycemic
control.Podiatry recommended continued current managment.
Consider radical soft tissue debridment of right foot.
[**2104-8-17**] patient 's WBC showed improvement. 14.4 Digoxin level
was 0.6 and his digoxin was restarted.Blood cultures positive
gram positive cocci.along with wound culture.
cardology consulted. P mibi recommended
7/26/04abnormal P mibi. Echo obtained to asses left ventricular
function.EF 30% with multiple reginol wall motion
abnormalities.Patient at considerable cardiac risk. This was
discussed with Dr. [**Last Name (STitle) **]  by DR. [**Last Name (STitle) **] [**Name (STitle) 19671**] consultant.
[**2104-8-19**] transfered to VICU
[**2104-8-25**] angiogram with angioplasty and stenting of right TPT.
[**2104-8-27**] debridment of right TMa VAC dressing application.
[**2104-8-28**] urine c/s and urinalysis sent for mucous in urine.
urinalysis was positive. Foley was removed. patient continued on
antibiocs. wound c/s and bone c/s postive for MRSA.
[**2104-9-2**] right TMA. Infectious disease consulted. Lenght of
antibiotic for MRSA  six weeks since bone culture positive.
[**2104-9-3**] inital dressing removed. skin edges well approximated.
no erythema.no drainage. ambulation strict nonweight bearing.
Seen by physical theraphy who recommends rehab at discharge
prior returning home. [**Last Name (un) **] continued to follow patient and
adjust insluin dosing.
[**2104-9-5**] levofloxcin discontinued.
[**9-6**] flagyl dicontinued anerobic cultures  no growth.
[**2104-9-9**] PICC line placed. wbc 10.0 bun/cr. 18/0.6.
8/.17/04 discharged afebrile and stable


Medications on Admission:
medrol 4mgm qd
surfate 240mgm qbid
magoxide 400mgm [**Hospital1 **]
insulin Humelin N 100 u [**Hospital1 **]
insulin Humellin R  [**Hospital1 **]
pravachol 40mgm HS
rinitidine 150mgm [**Hospital1 **]
ASA 81 mgm qd
lanoxin 125mgm qd
atrovent MDI prn
enalapril 5mgm dq
fosmax 70mgm q week
combivent MDI
Flovent MDI
Imdur 20mgm qd
lasix 20mgm qd


Discharge Medications:
1. Aspirin 325 mg Tablet Sig: One (1) Tablet PO QD (once a day).

2. Albuterol-Ipratropium 103-18 mcg/Actuation Aerosol Sig: [**1-25**]
Puffs Inhalation Q6H (every 6 hours) as needed.
3. Fluticasone Propionate 110 mcg/Actuation Aerosol Sig: Two (2)
Puff Inhalation [**Hospital1 **] (2 times a day).
4. Methylprednisolone 4 mg Tablet Sig: One (1) Tablet PO QD
(once a day).
5. Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every
4 to 6 hours) as needed.
6. Codeine-Guaifenesin 10-100 mg/5 mL Syrup Sig: 5-10 MLs PO Q6H
(every 6 hours) as needed.
7. Famotidine 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12
hours).
8. Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation
Q6H (every 6 hours) as needed.
9. Sodium Chloride 0.65 % Aerosol, Spray Sig: [**1-25**] Sprays Nasal
QID (4 times a day) as needed.
10. Clopidogrel Bisulfate 75 mg Tablet Sig: One (1) Tablet PO QD
(once a day).
11. Captopril 12.5 mg Tablet Sig: 0.5 Tablet PO TID (3 times a
day).
12. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID
(2 times a day).
13. Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal
QD (once a day) as needed.
14. Sodium Chloride 0.9%  Flush 3 ml IV QD:PRN
Peripheral IV - Inspect site every shift
15. Vancomycin HCl 1000 mg IV Q18H
Previously approved by ID.
16. Insulin Glargine 100 unit/mL Solution Sig: Eighteen (18)
units Subcutaneous at bedtime.
17. Insulin Lispro (Human) 100 unit/mL Solution Sig: as directed
 Subcutaneous four times a day: Humalog  breakfast/dinner:
glucose < 80/ no insulin
glucose 81-120/3u
glucose 121-160/5u
glucose 161-200/10u
glucose 201-240/12u
glucose 241-280/14u
glucoses 281-320/16u
glucose 321-360/18u
glucose 361-400/20u
glucose > 400/ [**Name8 (MD) 138**] MD.
Lunch:
glucoses <160/ no insulin
glucoses 161-200/2u
glucose 201-240/6u
glucose 241-280/8u
glucose 281-320/10u
glucose 321-360/12u
glucose 361-400/14u
HS:
glucoses<240/no insulin
glucose 241-280/2u
glucose 281-320/4u
glucose 321-360/6u
glucose 361-400/8u
glucose > 400 [**Name8 (MD) 138**] MD. .


Discharge Disposition:
Extended Care

Facility:
[**Hospital1 700**] - [**Location (un) 701**]

Discharge Diagnosis:
osteomylitis rt. foot s/p Right TMA
MRSA wound infection

Discharge Condition:
stable

Discharge Instructions:
Moniter ESR while on antibiotics.
trough level q week.
contiune antibiotic for 6 weeks from [**2104-9-2**]
finger glucoses qid

Followup Instructions:
2 weeks Dr.[**Last Name (STitle) **]. call for appointment. [**Telephone/Fax (1) 1784**]



Completed by:[**2104-9-9**]